PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA.\', \'Dana-Farber Cancer Institute, Boston, Massachusetts, USA.\', \'Center for the AIDS Programme of Research in South Africa, Durban, South Africa.\', \'Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.\', \'University of New South Wales, Sydney, Australia.\', \'Monash University, Melbourne, Australia.\', \'Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, USA.\', \'Vaccine and Immunotherapy Center, Massachusetts General Hospital, Boston, Massachusetts, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1093/infdis/jiab593
?:hasPublicationType
?:journal
  • The Journal of infectious diseases
is ?:pmid of
?:pmid
?:pmid
  • 34888672
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Comparative Immunogenicity and Effectiveness of mRNA-1273, BNT162b2, and Ad26.COV2.S COVID-19 Vaccines.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all